Antioxidant activities of retinoidal benzimidazole or indole derivatives in In vitro model systems

Current Medicinal Chemistry

Volumn 20, Issue 36, 2013, Pages 4633-4639

  Ates Alagoz, Zeynep ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Anticancer; Antioxidant compounds; Free radicals; Indole derivatives; Lipid peroxidation; Retinoids; Retinol

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; ANTIOXIDANT; BENZIMIDAZOLE; FENRETINIDE; FREE RADICAL; INDOLE DERIVATIVE; MELATONIN; OXYGEN; PEROXIDASE; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; TRANSITION ELEMENT;

ANTIOXIDANT ACTIVITY; ARTERIOSCLEROSIS; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CELL MEMBRANE; HUMAN; IN VITRO STUDY; LIPID OXIDATION; LIPID PEROXIDATION; MICROSOME; NEOPLASM; NEPHRITIS; OXIDATIVE STRESS; PROPHYLAXIS;

ANIMALS; ANTIOXIDANTS; BENZIMIDAZOLES; HUMANS; INDOLES; OXIDATIVE STRESS; RETINOIDS;

EID: 84887958643     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113209990150     Document Type: Article

References (59)

1. McCord, J. M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med., 1986, 312, 159-162.
2. Olanow, C. W. Oxidation reactions in Parkinson's disease. Neurology, 1990, 40(Suppl. 3), 32-37.
3. Martinez-Cayuela, M. Oxygen free radicals and human disease. Biochimie, 1955, 77, 147-161.
4. Schreck, R.; Bauerle, R.A. A role for oxygen radicals as second messengers. Trends Cell Biol., 1991, 1, 39-42.
5. Fridovich, I. The biology of oxygen radicals. Science, 1978, 201, 875-880.
6. Dong, Y.; Venkatachalam, T.K.; Narla, R.K.; Trieu, V.N.; Sudbeck, E.A.; Uckun, F.M. Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity. Bioorg. Med. Chem. Lett., 2000, 10, 87-90.
7. Tallman, M.S.; Wiernik, P. H. Retinoids in cancer treatment. J. Clin. Pharmacol., 1992, 32, 868-888.
8. Samokyszyn, V.M.; Marnett, L. J. Inhibition of microsomal lipid peroxidation by 13-cis-retinoic acid. Meth. Enzymol., 1990, 190, 281-288.
9. Levin, G.; Mokady, S. Antioxidant activity of 9-cis compared to all-trans beta-carotene in vitro. Free Rad. Biol. Med., 1994, 17, 77-82.
10. Rice-Evans, C. A.; Diplock, A. T. Eds. Techniques in Free Radical Research. Elsevier, Amsterdam, 1991, p 291.
11. Chomienne, C.; P. Fenaux, P.; Degos, I. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J., 1996, 10, 1025-1030.
12. Reiter, R.; Tan, D.; Osuna, C.; Gitto, E. Actions of melatonin in the reduction of oxidative stress. A review. J. Biomed. Sci., 2000, 7, 444-458.
13. Cuzzocrea, S.; Constantino, G.; Mazzon, E.; Micali, A.; De Sarro, A.; Caputi, A. P. Bene cial effects of melatonin in a rat model of splanchnic arteryocclusion and reperfusion. J. Pineal. Res., 2000, 28, 52-63.
14. Reiter, R. Aging and oxygen toxicity: relation to changes in melatonin. Age, 1997, 20, 201-213
15. Sies, H. Physiological society symposium: impaired endothelial and smooth muscle cell function in oxidative stress: oxidants and antioxidants. Experimental Physiology, 1997, 82, 291-295.
16. Södergren, E. Lipid Peroxidation in vivo: Evaluation and Application of Methods for Measurement. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 949), Acta Universitatis Upsaliensis, Uppsala.
17. Reiter, R. J. Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol., 1998, 56, 359-384.
18. Manda, G.; NechiforM. T.; Neagu, T-M. Reactive Oxygen Species, Cancer and Anti-Cancer Therapies. Curr. Chem. Biol., 2009, 3, 342-366.
19. Levine, R. L.; Stadtman, E. R. Oxidation of proteins during aging. Generations, 1992, 14, 39-42.
20. Allen, R. G.; Tresini, M. Oxidative stress and gene regulation. Free Radic. Biol. Med., 2000, 28(3), 463-499.
21. Poeggeler, B.; Reiter, R. J.; Tan, D. X.; Chen, L. D.; Manchester, L. C. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J. Pineal. Res., 1993, 14, 151-168.
22. Emerit, J.; Edeas, M.; Bricaire, F. Neurodegenerative diseases and oxidative stres. Biomed. Pharmacother., 2004, 58, 39-46.
23. Rexer, B. N.; Zheng, W. L.; Ong, D. E. Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. Cancer Res., 2001, 61(19), 7065-7070.
24. H. Nau and W. J. Blanner, Editors, Retinoids. The Biochemical and Molecular Basis of Vitamin A and Retinoic Action, Springer, New York 1999.
25. Sporn, M. B.; Roberts, A. B. Role of retinoids in differentiation and carcinogenesis. Cancer Res., 1983, 43, 3034-3040.
26. Hiramatsu, M.; Packer, L. Antioxidant activity of retinoids. Method. Enzymol., 1990, 190, 273-280.
27. Gianni, M.; Li Calzi, M.; Terao, M.; Guiso, G.; Caccia, S.; Barbui, T.; Rambaldi, A.; Garattini, E. AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-diff erentiating eff ects on acute promyelocytic leukemia cells. Blood, 1996, 87, 1520-1531.
28. Fitzgerald, P.; Teng, M.; Chandraratna, R. A.; Heyman, R. A.; Allegretto, E. A. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res., 1997, 57, 2642-2645.
29. Takahashi, N.; Tamagawa, K.; Kubo, Y.; Fukui, T.; Wakabayashi, H.; and Honda, T. Enhancement of Antioxidant Activity of p-Alkylaminophenols by Alkyl Chain Elongation. Bioorg. Med. Chem., 2003, 11, 3255-3260.
30. Stolc S. Indole derivatives as neuroprotectants. Life Sci., 1999, 65(18-19), 1943-1950.
31. Karbownik, M.; Reiter, R. Antioxidative effects of melatonin in protection against cellular damage caused ionizing radiation. Proc. Soc. Exp. Biol. Med., 2000, 225, 9-22.
32. Arendt, J.; Boberly, A. A.; Franey, C.; Wright, J. The effects of chronic, small doses of melatonin given in the late afternoon on fatigue in man. Neurosci. Lett., 1984, 45, 317-321.
33. Guardiola-Lemaitre, B. Toxicology of melatonin. J. Biol. Rhythms., 1997, 12(6), 697-706.
34. Seltzer, A.; Viswanathan, M.; Sazwedra, J. M. Melatonin-binding sites in brain and caudal arteries of the female rat during the estrous cycle and after estrogen administration. Endocrinology, 1992, 130, 1896-1902.
35. Ates, Z.; Can-Eke, B.; Suzen, S.; Iscan, M.; Buyukbingol, E. Effects of a Benzimidazole Compound on Monooxygenase Activities. Farmaco., 1997, 52, 703-706.
36. Ates-Alagoz, Z.; Buyukbingol, E. Synthesis of Some New Tetrahydronapthalene Benzimidazole Derivatives. Heterocycl. Commun., 2001, 7, 455-460.
37. Ates-Alagoz, Z.; Can-Eke, B.; Çoban, T.; Iscan, M.; Buyukbingol, E. Antioxidant Properties of Novel Benzimidazole Retinoids. Arch. Pharm. Pharm. Med. Chem., 2004, 337, 188-192.
38. Yang, X. L.; Wang, A. H. J. Structural studies of atom-specific anticancer drugs acting on DNA. Pharmacol. Therap., 1999, 83, 181-215.
39. Huq, F.; Yu J., Q.; Daghiri, H.; Beale, P. Studies on activities, cell uptake and DNA binding of four trans-planaramineplatinum(II) complexes of the form: trans-PtL(NH3)Cl2, where L=2-hydroxypyridine, imidazole, 3-hydroxypyridine and imidazo(1,2)pyridine. J. Inorg. Biochem., 2004, 98, 1261-1270.
40. Shaikh, S. A.; Ahmed, S. R.; Jayaram, B. A molecular thermodynamic view of DNA-drug interactions: a case study of 25 minorgroove binders. Arch. Biochem. Biophys., 2004, 429, 81-99.
41. Suh, D.; Oh, Y.-K.; Chaires, J. B. Determining the binding modes of DNA sequence specific compounds. Process Biochem., 2001, 37, 521-525.
42. Piskin, A. K.; Ates-Alagoz, Z.; Atac, F. B.; Musdal, Y.; Buyukbingol, E. DNA Binding and Antiproliferative Effects of Some Benzimidazole Retinoids. Turkish J. Biochem., 2009, 34(1), 39-43.
43. Balaban, F.; Ates-Alagoz, Z.; Buyukbingol, E.; Iscan, M. Genotoxicity studies on benzimidazole retinoids. Pharmazie, 2005, 60(11), 861-868.
44. Schaefer, D. M.; Liu, Q.; Faustman, C.; Yin, M. C. Supranutritional Administiration of Vitamins E and C mproves Oxidative Stability of Beef. J. Nutr., 1995, 125, 1792-1798.
45. Kombrust, D. J; Mavis, R. D. Microsomal Lipid Peroxidation II. Stimulation by Carbon Tetrachloride. Mol. Pharmacol., 1980, 17, 408-414.
46. Dix, T. A.; Aikens, J. Mechanisms and biological relevance of lipid peroxidation initiation. Chem. Res. Toxicol., 1993, 6(1), 2-18.
47. Parke, D. V.; Ioannides, C.; Lewis. D. F. V. The role of the cytochromes P450 in the detoxication and activation of drugs and other chemicals. Can. J. Physiol. Pharmacol., 1991, 69, 537-549.
48. Olgen, S.; Coban, T. Synthesis and antioxidant properties of novel N-substituted indole-2-carboxamide and indole-3-acetamide derivatives. Arch. Pharm. Med. Chem., 2002, 7, 331-338.
49. Ayhan-Kilcigil, G.; Kus, C.; Coban, T.; Can-Eke, B.; Iscan, M. Synthesis, antioxidant and radical scavenging activities of novel benzimidazoles. J. Enz. Inhib. Med. Chem., 2004, 19, 129-135.
50. Ohkawa, S.; Terao, S.; Terashita, Z.; Shibouta, Y.; Nishikawa, K. Dual inhibitors of thromboxane A2 synthet se and 5-lipoxygenase with scavenging activity of active oxygen species (AOS). Synthesis of a novel series of (3-pyridyl) methylbenzoquinone derivatives. J. Med. Chem., 1991, 34, 267-276.
51. Xanthopoulou, N.J.; Kourounakis, A. P.; Spyroudis, S.; Kourounakis, P. N. Synthesis and activity on free radical processes and inflammation of 5,8-dimethoxy-triptycene-quinones. Eur. J. Med. Chem., 2003, 38, 621-626.
52. Ates-Alagoz, Z.; Kus, C.; Çoban, T. Synthesis and antioxidant properties of some novel benzimidazoles containing substituted indole or 1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-naphthalene fragments. J. Enzyme Inhib. Med. Chem., 2005, 20(4), 325-331.
53. Becker, E. M.; Nissen, L. R.; Skibsted, L. H. Antioxidant evaluation protocols: Food quality or health effects. Eur. Food Res. Technol., 2004, 219, 561-571.
54. Ates-Alagoz, Z.; Çoban, T.; Buyukbingol, B. Synthesis and Antioxidant Activity of New Tetrahydro-Naphthalene-Indole Derivatives as Retinoid and Melatonin Analogs. Arch. Pharm. Chem. Life Sci., 2006, 339, 193-200.
55. Oda, Y.; Nakamura, H.; Oki, I.; Kato, T. Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens. Mutat. Res., 1985, 147, 219-229.
56. Hammer, B.; Bihari, N.; Reifferscheid, G.; Zahn, R. K.; Muller, W. E. G.; Batel, R. Evaluation of the SOS/umu-test post-treatment assay for the detection of genotoxic activities of pure compounds and complex environmental mixtures. Mutat. Res., 2000, 466, 161-171.
57. Reifferscheid, G.; Heil, J. Validation of the SOS/umu test using test results of 486 chemicals and comparison with the Ames test and carcinogenicity data. Mutat. Res., 1996, 369, 129-145.
58. Yasunaga, K.; Kiyonari, A.; Oikawa, T.; Abe, N.; Yoshikawa, K. Evaluation of the Salmonella umu test with 83 NTP chemicals. Environ. Mol. Mutagen., 2004, 44, 329-345.
59. Somay, T.; Durusoy, M.; Ates-Alagoz, Z.; Buyukbingol, E. Genotoxicity Studies of Tetrahydro-Naphthalene-Benzimidazole/ Thiazolidinedione as Retinoid Derivatives. Submitted for publication, 2012.